Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hippo Holdings (HIPO) Cash & Equivalents (2020 - 2026)

Hippo Holdings filings provide 7 years of Cash & Equivalents readings, the most recent being $275.4 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 52.83% to $275.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $275.4 million, a 52.83% increase, with the full-year FY2025 number at $218.3 million, down 6.23% from a year prior.
  • Cash & Equivalents hit $275.4 million in Q1 2026 for Hippo Holdings, up from $218.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $392.9 million in Q3 2022 to a low of $180.2 million in Q1 2025.
  • Median Cash & Equivalents over the past 5 years was $238.4 million (2023), compared with a mean of $255.0 million.
  • The widest YoY moves for Cash & Equivalents: up 321044.04% in 2022, down 70.14% in 2022.
  • Hippo Holdings' Cash & Equivalents stood at $244.5 million in 2022, then dropped by 20.2% to $195.1 million in 2023, then rose by 19.32% to $232.8 million in 2024, then decreased by 6.23% to $218.3 million in 2025, then rose by 26.16% to $275.4 million in 2026.
  • The last three reported values for Cash & Equivalents were $275.4 million (Q1 2026), $218.3 million (Q4 2025), and $247.7 million (Q3 2025) per Business Quant data.